# Study in Healthy Adult Male Participants to Gather Information How the Human Body Absorbs, Distributes and Excretes the Study Drug Selitrectinib Including the Effect of the Interaction of Food With the Study Drug on the Human Body

> **NCT04275960** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 24 (actual)

## Conditions studied

- Solid Tumors Harboring NTRK Fusion

## Interventions

- **DRUG:** Selitrectinib (BAY2731954)

## Key facts

- **NCT ID:** NCT04275960
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-28
- **Primary completion:** 2020-10-01
- **Final completion:** 2020-11-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04275960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04275960, "Study in Healthy Adult Male Participants to Gather Information How the Human Body Absorbs, Distributes and Excretes the Study Drug Selitrectinib Including the Effect of the Interaction of Food With the Study Drug on the Human Body". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04275960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*